For individuals diagnosed with celiac disease, adhering to a gluten-free diet is not merely a choice but a necessary treatment. Unfortunately, in Estonia, unlike various European countries, patients bear the full financial burden of gluten-free products.
Celiac disease is a chronic autoimmune disorder influenced by genetics, which is triggered by the ingestion of gluten. Gluten, a protein present in grains like wheat, barley, and rye, provokes an immune response that damages the lining of the small intestine in affected individuals.
Symptoms can vary widely, including fatigue, nausea, and abdominal pain, and can escalate to severe complications such as liver dysfunction, neurological issues, or recurrent miscarriage (RPL).
It is important to differentiate celiac disease from non-celiac gluten sensitivity (NCGS). While NCGS can cause similar symptoms, it does not result in the intestinal damage seen in celiac disease.
Currently, the only effective treatment for celiac disease is strict adherence to a gluten-free diet, as highlighted by Aive Antson, chair of the Estonian Celiac Society (ETS). She stated, “At present, science has no other pill, injection, or medication available for us.”
However, gluten-free products are generally more expensive than their regular counterparts, and like all groceries, their prices have surged due to inflation.
Antson pointed out that Estonia lacks comprehensive research on the price disparity between gluten-free and standard foods across various categories. Yet, the ETS performed its own study in late 2024, revealing that bread exhibited the most significant price gap.
No Additional Support in Estonia
A study by the Ministry of Social Affairs indicated that monthly grocery bills for individuals with celiac disease average approximately €90. This figure also encompassed services such as dietitian consultations, and it has likely increased since then.
Despite the necessity of a special diet for managing celiac disease, Estonia does not offer any financial support or reimbursement for gluten-free food products.
In contrast, several European nations have implemented measures to alleviate the financial strain. In Finland, low-income patients can apply for assistance with food expenses. Ireland provides tax relief for gluten-free food purchases, supplemented by additional support for those in financial distress, while Italy offers food vouchers. In the U.K., gluten-free products may even be available by prescription, depending on the region.
Karmen Joller, the Minister of Social Affairs, acknowledged that this issue has not been a recent topic of discussion but recognized the need for potential solutions. “Since this is essentially therapeutic food, it should either be covered by the Estonian Health Insurance Fund (EHIF) or perhaps compensated through rehabilitation services,” she stated.
However, EHIF clarified that it cannot fund everyday food purchases through health insurance. “EHIF pays for healthcare services that are included in the official list of healthcare services,” the agency noted in a written comment, emphasizing that medications are reimbursed based on a central list of subsidized pharmaceuticals. The agency added that decisions regarding treatment reimbursements are based on medical evidence, effectiveness, and cost considerations.
Celiac Society: We’ve Run Out of Steam
Antson mentioned that the Estonian Celiac Society has not engaged in substantial discussions with policymakers in several years. “The ETS celebrates its 30th anniversary this year,” she said. “We were more active in the society’s early years and even 10-15 years ago, but in recent years, we’ve run out of steam because our proposals haven’t progressed.”
Nonetheless, the organization aims to reignite these discussions by gathering updated data on the expenses associated with gluten-free diets and the extra costs faced by individuals with celiac disease and their families. Upon compiling this information, Antson remarked that the ETS intends to present it to Estonian policymakers.
She also stressed the necessity of enhanced collaboration with healthcare practitioners, noting that celiac disease often goes underdiagnosed across Europe. “Individuals frequently visit doctors with various symptoms for years — or even decades,” Antson added.
—
